File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jpainsymman.2006.07.018
- Scopus: eid_2-s2.0-33846828474
- PMID: 17280923
- WOS: WOS:000244268800009
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Taiwanese Version of the M. D. Anderson Symptom Inventory: Symptom Assessment in Cancer Patients
Title | Taiwanese Version of the M. D. Anderson Symptom Inventory: Symptom Assessment in Cancer Patients |
---|---|
Authors | |
Keywords | Taiwan validation assessment tool reliability sensitivity validity symptoms |
Issue Date | 2007 |
Citation | Journal of Pain and Symptom Management, 2007, v. 33, n. 2, p. 180-188 How to Cite? |
Abstract | The purpose of this study was to validate the Taiwanese version of the M. D. Anderson Symptom Inventory (MDASI-T) in a sample of 556 Taiwanese patients with multiple diagnoses of cancer. The internal consistency Cronbach alpha was 0.89 for symptom severity items and 0.94 for interference items. The test-retest reliability was 0.97 for the severity composite score and 0.96 for the interference composite score over a 3-day interval in a sample of 12 patients. Construct validity was established by factor analysis, which revealed a two-factor structure. Concurrent validity was examined by correlating the MADSI-T scores and scores of the Medical Outcome Study 36-Item Short-Form Health Survey. Known-group validity was established by comparing MDASI-T scores between patients having low functional status and those having high functional status (Karnofsky Performance Status scores ≤50 or >50, respectively) and between inpatients and outpatients. The MDASI-T's sensitivity (its ability to detect small differences in reporting variations) was examined by comparing the MDASI-T composite symptom scores and composite interference scores before, during, and one week after treatment in a sample of 20 breast cancer patients receiving chemotherapy. The MDASI-T is a reliable, valid, and sensitive instrument for measuring the severity and interference with daily life of cancer-related symptoms among Taiwanese cancer patients. © 2007 U.S. Cancer Pain Relief Committee. |
Persistent Identifier | http://hdl.handle.net/10722/241143 |
ISSN | 2023 Impact Factor: 3.2 2023 SCImago Journal Rankings: 1.186 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lin, Chia Chin | - |
dc.contributor.author | Chang, Ai Ping | - |
dc.contributor.author | Cleeland, Charles S. | - |
dc.contributor.author | Mendoza, Tito R. | - |
dc.contributor.author | Wang, Xin Shelley | - |
dc.date.accessioned | 2017-05-26T03:36:56Z | - |
dc.date.available | 2017-05-26T03:36:56Z | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | Journal of Pain and Symptom Management, 2007, v. 33, n. 2, p. 180-188 | - |
dc.identifier.issn | 0885-3924 | - |
dc.identifier.uri | http://hdl.handle.net/10722/241143 | - |
dc.description.abstract | The purpose of this study was to validate the Taiwanese version of the M. D. Anderson Symptom Inventory (MDASI-T) in a sample of 556 Taiwanese patients with multiple diagnoses of cancer. The internal consistency Cronbach alpha was 0.89 for symptom severity items and 0.94 for interference items. The test-retest reliability was 0.97 for the severity composite score and 0.96 for the interference composite score over a 3-day interval in a sample of 12 patients. Construct validity was established by factor analysis, which revealed a two-factor structure. Concurrent validity was examined by correlating the MADSI-T scores and scores of the Medical Outcome Study 36-Item Short-Form Health Survey. Known-group validity was established by comparing MDASI-T scores between patients having low functional status and those having high functional status (Karnofsky Performance Status scores ≤50 or >50, respectively) and between inpatients and outpatients. The MDASI-T's sensitivity (its ability to detect small differences in reporting variations) was examined by comparing the MDASI-T composite symptom scores and composite interference scores before, during, and one week after treatment in a sample of 20 breast cancer patients receiving chemotherapy. The MDASI-T is a reliable, valid, and sensitive instrument for measuring the severity and interference with daily life of cancer-related symptoms among Taiwanese cancer patients. © 2007 U.S. Cancer Pain Relief Committee. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Pain and Symptom Management | - |
dc.subject | Taiwan | - |
dc.subject | validation | - |
dc.subject | assessment tool | - |
dc.subject | reliability | - |
dc.subject | sensitivity | - |
dc.subject | validity | - |
dc.subject | symptoms | - |
dc.title | Taiwanese Version of the M. D. Anderson Symptom Inventory: Symptom Assessment in Cancer Patients | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.jpainsymman.2006.07.018 | - |
dc.identifier.pmid | 17280923 | - |
dc.identifier.scopus | eid_2-s2.0-33846828474 | - |
dc.identifier.volume | 33 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 180 | - |
dc.identifier.epage | 188 | - |
dc.identifier.isi | WOS:000244268800009 | - |
dc.identifier.issnl | 0885-3924 | - |